Market Place
Sourcing Support
Panacea Biotec, Apotex Settle Collaboration Agreement Breach
09 Jul 2025 //
ECONOMICTIMES
Apotex Launches Generic Tasigna Capsules in Us with Exclusivity
27 May 2025 //
PR NEWSWIRE
Formosa Pharmaceuticals Licenses Clobetasol Propionate to Apotex
06 May 2025 //
PR NEWSWIRE
Apotex licenses Canadian rights to Qutenza® from Grünenthal
24 Feb 2025 //
PR NEWSWIRE
Apotex Grants $242K To Support Maternal Health In Broward County
13 Feb 2025 //
PR NEWSWIRE
Health Canada Issues Recalls of Apotex`s Quetiapine
31 Jan 2025 //
HEALTH CANADA
Apotex acquires US rights to Provigil and Nuvigil
09 Jan 2025 //
PR NEWSWIRE
Apotex`s Generics Rivaroxaban HCl Receives Approval in US
07 Nov 2024 //
FDA
Apotex, Heritage fork over $49M to resolve price-fixing claims
01 Nov 2024 //
FIERCE PHARMA
Apopharma`s Generics Rivaroxaban Receives Tentative Approval in US
15 Oct 2024 //
FDA
Apotex Launches First Generic Dasatinib Tablets in the United States
04 Sep 2024 //
PR NEWSWIRE
Formosa Pharma Licenses Clobetasol Eye Drug To Apotex
05 Aug 2024 //
PR NEWSWIRE
Apotex`s Generic Bromfenac Sodium Receives Approval in US
08 Jul 2024 //
FDA
Court Allows Vanda`s HETLIOZ Patent Lawsuit Against Teva And Apotex
01 Jul 2024 //
PR NEWSWIRE
Apotex`sGeneric Pomalidomide Receives Approval in US
11 Jun 2024 //
FDA
Apotex`s Generic Zinc Sulfate Receives Approval in US
10 Jun 2024 //
FDA
Apotex`s Generic Losartan Potassium Receives Approval in US
04 Jun 2024 //
FDA
Apotex to Participate in the Jefferies Global Healthcare Conference 2024
04 Jun 2024 //
PR NEWSWIRE
Apotex Acquires Canadian Specialty Pharma Searchlight
03 Jun 2024 //
PR NEWSWIRE
Apotex`s Generic Emtricitabine;TAF Receives Approval in the U.S.
17 May 2024 //
FDA
Apotex`s Generic Mometasone Furoate Receives Approval in the U.S.
23 Apr 2024 //
FDA
Apotex to Acquire Searchlight Pharma, a Canadian Branded Pharmaceutical Leader
02 Apr 2024 //
PR NEWSWIRE
Apotex to acquire Canadian Searchlight Pharma
02 Apr 2024 //
INDIANPHARMAPOST
Harrow Licenses Canadian Rights to Apotex for Ophthalmic Products
15 Feb 2024 //
BUSINESSWIRE
Apotex and 2 others settle in long-running price-fixing suit
24 Jan 2024 //
FIERCE PHARMA
Apotex Inc`s Generic Brexpiprazole Receives Approval in the U.S.
13 Dec 2023 //
FDA
Ambio Announces US FDA Approval of a Generic Version of Forteo
01 Dec 2023 //
BUSINESSWIRE
Apotex Corp. Launches Teriparatide Injectable for Osteoporosis Treatment
21 Nov 2023 //
PR NEWSWIRE
Apotex`s Generic Brivaracetam Receives Approval in the U.S.
06 Nov 2023 //
FDA
Apotex`s Generic Dexamethasone Receives Approval in the U.S.
23 Aug 2023 //
FDA
FDA to import more of cancer drug from China
12 Jul 2023 //
ENDPTS
Apotex`s Generic Vilazodone Hydrochloride Receives Approval in the U.S.
07 Jul 2023 //
FDA
Apotex`s Generic Pirfenidone Receives Approval in the U.S.
09 Jun 2023 //
FDA
Apotex`s Generic Bendamustine Hydrochloride Receives Approval in the U.S.
05 Jun 2023 //
FDA
Apotex`s Generic Obeticholic Acid Receives Receives Approval in the U.S.
30 May 2023 //
FDA
Apotex Corp. Launches Bendamustine Hydrochloride Injection in the United States
26 Apr 2023 //
PR NEWSWIRE
Apotex issues recall of eye treatment over cracked bottle caps
09 Mar 2023 //
ENDPTS
Apotex`s Generic Lenalidomide Receives Approval in the U.S.
07 Mar 2023 //
FDA
Apotex yanks 6 batches of glaucoma med on sterility concerns
03 Mar 2023 //
FIERCE PHARMA
Apotex`s Generic Cabazitaxel Receives Approval in the U.S.
10 Feb 2023 //
FDA
Apotex`s Generic Bendamustine Hydrochloride Receives Approval in the U.S.
10 Feb 2023 //
FDA
Apotex`s Generic Varenicline Tartrate Receives Approval in the U.S.
25 Jan 2023 //
FDA
Apotex`s Generic Triamcinolone Acetonide Receives Approval in the U.S.
19 Jan 2023 //
FDA
Apotex`s Generic Brimonidine Tartrate Receives Approval in the U.S.
21 Dec 2022 //
FDA
Apotex`s Generic Tasimelteon Receives Approval in the U.S.
20 Dec 2022 //
FDA
Vanda Pharmaceuticals Provides an Update to HETLIOZ ANDA Litigation Appeal
16 Dec 2022 //
PRNEWSWIRE
Teva, Apotex prevail over Vanda in patent infringement case
15 Dec 2022 //
FIERCEPHARMA
Takeda sues Apotex over prospective generic versions of its top leukemia drug
21 Oct 2022 //
ENDPTS
SK Capital to Acquire Apotex, a Global Leader in Affordable Pharmaceuticals
28 Sep 2022 //
BUSINESSWIRE
Apotex`s Generic Lacosamide Receives Approval in the U.S.
23 Sep 2022 //
FDA
Apotex`s Generic Gefitinib Receives Approval in the U.S.
23 Sep 2022 //
FDA
Apotex`s Generic Tolvaptan Receives Approval in the U.S.
06 Sep 2022 //
FDA
Apotex`s Generic Lenalidomide Receives Approval in the U.S.
30 Aug 2022 //
FDA
Apotex Inc Generic Fluphenazine Hydrochloride Receives Approval in the U.S.
15 Jul 2022 //
FDA
Apotex`s Generic Brivaracetam Receives Tentative Approval in the U.S.
12 Jul 2022 //
FDA
Scilex sues Apotex to block generic copy of key pain patch
28 Jun 2022 //
FIERCEPHARMA
Apotex Inc`s Generic Pemetrexed Receives Approval in the U.S.
25 May 2022 //
FDA
Apotex`s Generic Bortezomib Receives Approval in the U.S.
06 May 2022 //
FDA
Apotex`s Generic Bortezomib Receives Approval in the U.S.
02 May 2022 //
FDA
